{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:47:20Z","timestamp":1773690440039,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T00:00:00Z","timestamp":1412380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2458-14-1035","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T01:01:55Z","timestamp":1412384515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings"],"prefix":"10.1186","volume":"14","author":[{"given":"Raphael Z","family":"Sangeda","sequence":"first","affiliation":[]},{"given":"Fausta","family":"Mosha","sequence":"additional","affiliation":[]},{"given":"Mattia","family":"Prosperi","sequence":"additional","affiliation":[]},{"given":"Said","family":"Aboud","sequence":"additional","affiliation":[]},{"given":"Jurgen","family":"Vercauteren","sequence":"additional","affiliation":[]},{"given":"Ricardo J","family":"Camacho","sequence":"additional","affiliation":[]},{"given":"Eligius F","family":"Lyamuya","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Van Wijngaerden","sequence":"additional","affiliation":[]},{"given":"Anne-Mieke","family":"Vandamme","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,10,4]]},"reference":[{"key":"7132_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijid.2006.11.003","volume":"11","author":"R Chaiwarith","year":"2007","unstructured":"Chaiwarith R, Wachirakaphan C, Kotarathititum W, Praparatanaphan J, Sirisanthana T, Supparatpinyo K: Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand. Int J Infect Dis. 2007, 11: 413-416. 10.1016\/j.ijid.2006.11.003.","journal-title":"Int J Infect Dis"},{"key":"7132_CR2","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/cid\/cir729","volume":"53","author":"HE Rawizza","year":"2011","unstructured":"Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankal\u00e9 J-L, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ: Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011, 53: 1283-1290. 10.1093\/cid\/cir729.","journal-title":"Clin Infect Dis"},{"key":"7132_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/QAI.0b013e31824276e9","volume":"59","author":"A De Luca","year":"2012","unstructured":"De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AMD, Buonomo E, Prosperi MCF, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L: Prognostic value of virological and immunological responses after 6\u00a0months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2012, 59: 236-244. 10.1097\/QAI.0b013e31824276e9.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7132_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.7326\/0003-4819-146-8-200704170-00007","volume":"146","author":"JB Nachega","year":"2007","unstructured":"Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G: Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007, 146: 564-573. 10.7326\/0003-4819-146-8-200704170-00007.","journal-title":"Ann Intern Med"},{"key":"7132_CR5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ije\/dyp004","volume":"38","author":"BH Chi","year":"2009","unstructured":"Chi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, Tambatamba BC, Reid S, Mwango A, Mwinga A, Bulterys M, Saag MS, Stringer JSA: Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12\u00a0months in Lusaka, Zambia. Int J Epidemiol. 2009, 38: 746-756. 10.1093\/ije\/dyp004.","journal-title":"Int J Epidemiol"},{"key":"7132_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/QAD.0b013e32802e6bfa","volume":"21","author":"JH Oyugi","year":"2007","unstructured":"Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, Mugyenyi P, Quinn TC, Bangsberg DR: Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007, 21: 965-971. 10.1097\/QAD.0b013e32802e6bfa.","journal-title":"AIDS"},{"issue":"Suppl 3","key":"7132_CR7","doi-asserted-by":"publisher","first-page":"S272","DOI":"10.1086\/533415","volume":"197","author":"DR Bangsberg","year":"2008","unstructured":"Bangsberg DR: Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008, 197 (Suppl 3): S272-S278.","journal-title":"J Infect Dis"},{"key":"7132_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1365-3156.2012.02974.x","volume":"17","author":"S Kiwuwa-Muyingo","year":"2012","unstructured":"Kiwuwa-Muyingo S, Walker AS, Oja H, Levin J, Miiro G, Katabira E, Kityo C, Hakim J, Todd J: The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe. Trop Med Int Health. 2012, 17: 584-594. 10.1111\/j.1365-3156.2012.02974.x.","journal-title":"Trop Med Int Health"},{"key":"7132_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/01.qai.0000225015.43266.46","volume":"43","author":"JB Nachega","year":"2006","unstructured":"Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G: Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006, 43: 78-84. 10.1097\/01.qai.0000225015.43266.46.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7132_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jclinepi.2004.04.002","volume":"57","author":"R Grossberg","year":"2004","unstructured":"Grossberg R, Zhang Y, Gross R: A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004, 57: 1107-1110. 10.1016\/j.jclinepi.2004.04.002.","journal-title":"J Clin Epidemiol"},{"key":"7132_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/COH.0b013e328333ad61","volume":"5","author":"JB Nachega","year":"2010","unstructured":"Nachega JB, Mills EJ, Schechter M: Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS. 2010, 5: 70-77. 10.1097\/COH.0b013e328333ad61.","journal-title":"Curr Opin HIV AIDS"},{"key":"7132_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(11)70181-5","volume":"11","author":"T B\u00e4rnighausen","year":"2011","unstructured":"B\u00e4rnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell M-L: Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011, 11: 942-951. 10.1016\/S1473-3099(11)70181-5.","journal-title":"Lancet Infect Dis"},{"key":"7132_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11904-007-0027-4","volume":"4","author":"R Grossberg","year":"2007","unstructured":"Grossberg R, Gross R: Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV\/AIDS Rep. 2007, 4: 187-191. 10.1007\/s11904-007-0027-4.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"7132_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/09540120050042891","volume":"12","author":"MA Chesney","year":"2000","unstructured":"Chesney MA, Ickovics JR, Chambers DB: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000, 12: 255-266. 10.1080\/09540120050042891.","journal-title":"AIDS Care"},{"issue":"Suppl 1","key":"7132_CR15","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","volume":"43","author":"KM Berg","year":"2006","unstructured":"Berg KM, Arnsten JH: Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006, 43 (Suppl 1): S79-S87.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7132_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10461-006-9078-6","volume":"10","author":"JM Simoni","year":"2006","unstructured":"Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA: Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006, 10: 227-245. 10.1007\/s10461-006-9078-6.","journal-title":"AIDS Behav"},{"key":"7132_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10461-006-9122-6","volume":"10","author":"GJ Wagner","year":"2006","unstructured":"Wagner GJ: Utility of self-reported antiretroviral adherence: Comment on Simoni et al. (2006). AIDS Behav. 2006, 10: 247-248. 10.1007\/s10461-006-9122-6.","journal-title":"AIDS Behav"},{"key":"7132_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1590\/S0034-89102008000400025","volume":"42","author":"ET Santa Helena","year":"2008","unstructured":"Santa Helena ET, Nemes MI, Eluf-Neto J: Development and validation of a multidimensional questionnaire assessing non-adherence to medicines. Rev Saude Publica. 2008, 42: 764-767. 10.1590\/S0034-89102008000400025.","journal-title":"Rev Saude Publica"},{"key":"7132_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1001\/jama.296.6.679","volume":"296","author":"EJ Mills","year":"2006","unstructured":"Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR: Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006, 296: 679-690. 10.1001\/jama.296.6.679.","journal-title":"JAMA"},{"key":"7132_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/09540120903193708","volume":"22","author":"MH Watt","year":"2010","unstructured":"Watt MH, Maman S, Golin CE, Earp JA, Eng E, Bangdiwala SI, Jacobson M: Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care. 2010, 22: 381-389. 10.1080\/09540120903193708.","journal-title":"AIDS Care"},{"key":"7132_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/QAI.0b013e3181820141","volume":"49","author":"GP Bisson","year":"2008","unstructured":"Bisson GP, Rowh A, Weinstein R, Gaolathe T, Frank I, Gross R: Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr. 2008, 49: 107-110. 10.1097\/QAI.0b013e3181820141.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7132_CR22","unstructured":"WHO HIV Drug resistance report 2012. [\n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/75183\/1\/9789241503938_eng.pdf\n                    \n                  ]"},{"key":"7132_CR23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1089\/aid.2008.0035","volume":"24","author":"JD Goldman","year":"2008","unstructured":"Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid SE, Levy JW, Limbada M, Taylor A, Saag MS, Vermund SH, Stringer JSA, Chi BH: Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008, 24: 1031-1035. 10.1089\/aid.2008.0035.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"7132_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/cid\/ciq167","volume":"52","author":"JH McMahon","year":"2011","unstructured":"McMahon JH, Jordan MR, Kelley K, Bertagnolio S, Hong SY, Wanke CA, Lewin SR, Elliott JH: Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2011, 52: 493-506. 10.1093\/cid\/ciq167.","journal-title":"Clin Infect Dis"},{"key":"7132_CR25","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1345\/aph.1H018","volume":"40","author":"LM Hess","year":"2006","unstructured":"Hess LM, Raebel MA, Conner DA, Malone DC: Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006, 40: 1280-1288. 10.1345\/aph.1H018.","journal-title":"Ann Pharmacother"},{"key":"7132_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/apc.2007.0229","volume":"22","author":"AE Deschamps","year":"2008","unstructured":"Deschamps AE, De Geest S, Vandamme A-M, Bobbaers H, Peetermans WE, Van Wijngaerden E: Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS. 2008, 22: 735-743. 10.1089\/apc.2007.0229.","journal-title":"AIDS Patient Care STDS"},{"key":"7132_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s10461-008-9502-1","volume":"14","author":"TL Acri","year":"2010","unstructured":"Acri TL, TenHave TR, Chapman JC, Bogner HR, Gross R: Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence. AIDS Behav. 2010, 14: 748-754. 10.1007\/s10461-008-9502-1.","journal-title":"AIDS Behav"},{"key":"7132_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1097\/QAD.0b013e32833a097b","volume":"24","author":"Z El-Khatib","year":"2010","unstructured":"El-Khatib Z, Ekstrom AM, Ledwaba J, Mohapi L, Laher F, Karstaedt A, Charalambous S, Petzold M, Katzenstein D, Morris L, Ekstr\u00f6m AM: Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. AIDS. 2010, 24: 1679-1687. 10.1097\/QAD.0b013e32833a097b.","journal-title":"AIDS"},{"key":"7132_CR29","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1097\/QAD.0b013e32830e4cd8","volume":"22","author":"P Mee","year":"2008","unstructured":"Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD: Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS. 2008, 22: 1971-1977. 10.1097\/QAD.0b013e32830e4cd8.","journal-title":"AIDS"},{"key":"7132_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/01.qai.0000186371.95301.52","volume":"41","author":"TR Glass","year":"2006","unstructured":"Glass TR, De Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, Bucher HC: Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006, 41: 385-392. 10.1097\/01.qai.0000186371.95301.52.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7132_CR31","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2012","unstructured":"R Development Core Team: R: A Language and Environment for Statistical Computing. 2012"},{"key":"7132_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1145\/1656274.1656278","volume":"11","author":"M Hall","year":"2009","unstructured":"Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH: The WEKA data mining software. ACM SIGKDD Explor Newsl. 2009, 11: 10-10.1145\/1656274.1656278.","journal-title":"ACM SIGKDD Explor Newsl"},{"key":"7132_CR33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1468-1293.2005.00322.x","volume":"6","author":"CK Fairley","year":"2005","unstructured":"Fairley CK, Permana A, Read TRH: Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Med. 2005, 6: 366-369. 10.1111\/j.1468-1293.2005.00322.x.","journal-title":"HIV Med"},{"key":"7132_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1258\/ijsa.2009.009152","volume":"23","author":"SJ Kerr","year":"2012","unstructured":"Kerr SJ, Avihingsanon A, Putcharoen O, Chetchotisakd P, Layton M, Ubolyam S, Ruxrungtham K, Cooper DA, Phanuphak P, Duncombe C: Assessing adherence in Thai patients taking combination antiretroviral therapy. Int J STD AIDS. 2012, 23: 160-165. 10.1258\/ijsa.2009.009152.","journal-title":"Int J STD AIDS"},{"key":"7132_CR35","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1086\/507680","volume":"194","author":"R Gross","year":"2006","unstructured":"Gross R, Yip B, Lo Re V, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JSG, Hogg RS: A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006, 194: 1108-1114. 10.1086\/507680.","journal-title":"J Infect Dis"},{"key":"7132_CR36","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s10461-012-0168-3","volume":"16","author":"EB Gutierrez","year":"2012","unstructured":"Gutierrez EB, Sartori AMC, Schmidt AL, Piloto BM, Fran\u00e7a BB, de Oliveira AS, Pouza AR, Moreno RV, de Melo PC, de Almeida Ribeiro MCS: Measuring adherence to antiretroviral treatment: the role of pharmacy records of drug withdrawals. AIDS Behav. 2012, 16: 1482-1490. 10.1007\/s10461-012-0168-3.","journal-title":"AIDS Behav"},{"key":"7132_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-6405-6-21","volume":"6","author":"M Rougemont","year":"2009","unstructured":"Rougemont M, Stoll BE, Elia N, Ngang P: Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital Cameroon. AIDS Res Ther. 2009, 6: 21-10.1186\/1742-6405-6-21.","journal-title":"AIDS Res Ther"},{"key":"7132_CR38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1086\/507526","volume":"43","author":"DR Bangsberg","year":"2006","unstructured":"Bangsberg DR: Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006, 43: 939-941. 10.1086\/507526.","journal-title":"Clin Infect Dis"},{"key":"7132_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/QAI.0b013e3181befa12","volume":"53","author":"J Chalker","year":"2010","unstructured":"Chalker J, Wagner A, Tomson G, Laing R, Johnson K, Wahlstr\u00f6m R, Ross-Degnan D: Urgent need for coordination in adopting standardized antiretroviral adherence performance indicators. J Acquir Immune Defic Syndr. 2010, 53: 159-161. 10.1097\/QAI.0b013e3181befa12.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7132_CR40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/cid\/cis438","volume":"55","author":"J Luebbert","year":"2012","unstructured":"Luebbert J, Tweya H, Phiri S, Chaweza T, Mwafilaso J, Hosseinipour MC, Ramroth H, Schnitzler P, Neuhann F: Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi. Clin Infect Dis. 2012, 55: 441-448. 10.1093\/cid\/cis438.","journal-title":"Clin Infect Dis"},{"key":"7132_CR41","doi-asserted-by":"publisher","first-page":"274978","DOI":"10.5402\/2012\/274978","volume":"2012","author":"R Balikuddembe","year":"2012","unstructured":"Balikuddembe R, Kayiwa J, Musoke D, Ntale M, Baveewo S, Waako P, Obua C: Plasma drug level validates self-reported adherence but predicts limited specificity for nonadherence to antiretroviral therapy. ISRN Pharmacol. 2012, 2012: 274978-","journal-title":"ISRN Pharmacol"},{"key":"7132_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4314\/thrb.v10i2.14350","volume":"10","author":"OMS Minzi","year":"2008","unstructured":"Minzi OMS, Naazneen AS: Validation of self-report and hospital pill count using unannounced home pill count as methods for determination of adherence to antiretroviral therapy. Tanzan J Health Res. 2008, 10: 84-88.","journal-title":"Tanzan J Health Res"},{"key":"7132_CR43","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s11606-007-0171-y","volume":"22","author":"SC Kalichman","year":"2007","unstructured":"Kalichman SC, Amaral CM, Stearns H, White D, Flanagan J, Pope H, Cherry C, Cain D, Eaton L, Kalichman MO: Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007, 22: 1003-1006. 10.1007\/s11606-007-0171-y.","journal-title":"J Gen Intern Med"},{"key":"7132_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","volume":"15","author":"DR Bangsberg","year":"2001","unstructured":"Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A: Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001, 15: 1181-1183. 10.1097\/00002030-200106150-00015.","journal-title":"AIDS"},{"key":"7132_CR45","first-page":"872396","volume":"2010","author":"S Kunutsor","year":"2010","unstructured":"Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, Namagala E, Ikoona E: Clinic Attendance for Medication Refills and Medication Adherence amongst an Antiretroviral Treatment Cohort in Uganda: A Prospective Study. AIDS Res Treat. 2010, 2010: 872396-","journal-title":"AIDS Res Treat"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-1035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-14-1035\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-1035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-1035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T14:58:17Z","timestamp":1548169097000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-14-1035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["7132"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-14-1035","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,4]]},"assertion":[{"value":"17 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1035"}}